Y10S 977/801
Drug
Y10S977/801 (Drug) appears on 107 US grants and 42 published applications in this corpus.
Search patents in Y10S- Granted patents
- 107
- Published applications
- 42
- Assignees
- 71
- Inventors
- 185
- Latest grant
- 20 Oct 2015
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 3 | 0 |
| 1995 | 3 | 0 |
| 1996 | 8 | 0 |
| 1997 | 3 | 0 |
| 1998 | 17 | 0 |
| 1999 | 8 | 0 |
| 2000 | 19 | 0 |
| 2001 | 9 | 1 |
| 2002 | 7 | 3 |
| 2003 | 10 | 11 |
| 2004 | 2 | 5 |
| 2005 | 1 | 6 |
| 2006 | 1 | 2 |
| 2007 | 0 | 4 |
| 2008 | 3 | 1 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 6 | 2 |
| 2012 | 0 | 2 |
| 2013 | 2 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 2 |
By publication year. Applications have been published since 2001.
Recent patents
- Charge triggering of self-organized nanoparticles20 Oct 2015US 9,161,993 B2Danmarks Tekniske Universitet
- Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers24 Dec 2013US 8,613,929 B2To-Bbb Holding B.V.
- Liposomal formulations of anthracycline agents and cytidine analogs30 Apr 2013US 8,431,806 B2Celator Pharmaceuticals, Inc.
- Compositions and methods for treating B-cell malignancies29 Nov 2011US 8,067,011 B2Chimeros, Inc.
- Methods and compositions for targeting agents into and across the blood-barrier and other endothelial cell microvascular barriers27 Sep 2011US 8,026,209 B2BBB Holding B.V.
- Peptide Containing Porphyrin Lipid Nanovesicles11 May 2017US 2017/0128591 A1University Health Network
- Self-assembling nanoparticle drug delivery system4 May 2017US 2017/0119689 A1
- Charge triggering of self-organized nanoparticles6 Nov 2014US 2014/0328897 A1Danmarks Tekniske Universitet
- Self-assembling nanoparticle drug delivery system13 Dec 2012US 2012/0315335 A1
- Liposomal formulations of anthracycline agents and cytidine analogs12 Jan 2012US 2012/0009252 A1Celator Pharmaceuticals, Inc.
Most cited
By later US patents
- Intradermal drug delivery device and method for intradermal delivery of drugs690US 5,848,991 AElan Medical Technologies Limited Athlone, Co. · 1998
- Therapeutic drug delivery systems498US 5,580,575 AImaRx Pharmaceutical Corp. · 1996
- Means to achieve sustained release of synergistic drugs by conjugation378US 6,051,576 AUniversity of Kentucky Research Foundation · 2000
- Methods of preparing gas-filled liposomes362US 5,469,854 AImaR.sub.x Pharmaceutical Corp. · 1995
- Process for preparing therapeutic compositions containing nanoparticles359US 5,510,118 ANanoSystems L.L.C. · 1996